Answer
Dectova (zanamivir hydrate) is indicated from 6 months of age for complicated, potentially life-threatening influenza A or B when resistance to anti-influenza medicines other than zanamivir is known or suspected and/or other antivirals, including inhaled zanamivir, are unsuitable, and should be used according to official guidance.
Sources for this answer
- Dectova 10 mg/mL solution for infusionGlaxoSmithKline UK · emc · SmPC §4.1 Therapeutic Indications · Version 6Document updated
Sources checked